The Victorian Labor Government has announced Australia’s first globally recognised biorepository, Biobanking Victoria, months after the state-funded laboratory received its accreditation from the National Association of Testing Authorities (NATA) in November. “Biobanking Victoria is the culmination of years of hard work by a highly dedicated team,” said the Director of Biobanking Victoria, Prof. Melissa Southey. The $10 million (US$ 7.5 million) facility backed by the Monash University School of Clinical Sciences received its NATA accreditation on Nov. 23, 2021, and currently houses 4.5 million biological specimens from 6 clinical trials. In 2018, the Victorian Labor Government invested $1.5 million (US$1.13 million) into the facility as part of the Labor Government’s Future Industries Fund to “make critical discoveries and develop new treatments.” The biobank was developed in a collaboration with Rutgers University Cell and DNA Repository (RUCDR) Infinite Biologics in the U.S. RUCDR Infinite Biologics, also known as Infinite BiologiX (IBX), …